Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Revenue History
Annual and quarterly revenue from 2017 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
SHPH Revenue Growth
SHPH Revenue Analysis (2017–2024)
As of May 8, 2026, Shuttle Pharmaceuticals Holdings, Inc. (SHPH) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, SHPH's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including SENS (+78.9% YoY), NVCR (+8.5% YoY), and AGEN (+10.4% YoY). Compare SHPH vs SENS →
SHPH Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SHPHCurrent | $0 | - | - | - | |
 SENS | $35M | +78.9% | +48.1% | -193.8% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 AGEN | $114M | +10.4% | +5.3% | -18.0% |
SHPH Historical Revenue Data (2017–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $0 | - | $-7,696,170 | - |
| 2023 | $0 | - | $0 | - | $-5,892,382 | - |
| 2022 | $0 | - | $-5,972 | - | $-2,343,826 | - |
| 2021 | $0 | - | $-60,834 | - | $-1,742,992 | - |
| 2020 | $0 | - | $-54,951 | - | $-509,522 | - |
| 2018 | $0 | - | $-18,000 | - | $-586,630 | - |
| 2017 | $0 | - | $-18,739 | - | $-203,890 | - |
See SHPH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SHPH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SHPH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSHPH — Frequently Asked Questions
Quick answers to the most common questions about buying SHPH stock.
Is SHPH's revenue growth accelerating or slowing?
SHPH TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is SHPH's long-term revenue growth rate?
Shuttle Pharmaceuticals Holdings, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is SHPH's revenue distributed by segment?
SHPH reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2024 are available for download. Segment mix reveals concentration and diversification trends.